about
Targeting Protein-Protein Interactions in the HIF SystemXRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in MiceReduction-oxidation pathways involved in cancer development: a systematic review of literature reviews.ETS-targeted therapy: can it substitute for MEK inhibitors?A novel statistical approach for identification of the master regulator transcription factor.Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.Myogenic regulatory transcription factors regulate growth in rhabdomyosarcomaIdentification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network.ETV4 and AP1 Transcription Factors Form Multivalent Interactions with three Sites on the MED25 Activator-Interacting Domain.RegulatorTrail: a web service for the identification of key transcriptional regulators.Targeting hepatic glucose metabolism in the treatment of type 2 diabetes.Absorption, metabolism, anti-cancer effect and molecular targets of epigallocatechin gallate (EGCG): An updated review.Transcription factor proteomics-Tools, applications, and challenges.Nuclear factor one transcription factors as epigenetic regulators in cancer.Super-Enhancer-Driven Transcriptional Dependencies in Cancer.The Essential Transcriptional Function of BRD4 in Acute Myeloid Leukemia.Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer.Identification of breast cancer associated variants that modulate transcription factor binding.Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity.Targeting the Noncoding Genome: Superenhancers Meet Their Kryptonite.Selector genes display tumor cooperation and inhibition in Drosophila epithelium in a developmental context-dependent manner.Targeting Oncogenic Transcription Factors: Therapeutic Implications of Endogenous STAT Inhibitors.Inhibiting MYC binding to the E-box DNA motif by ME47 decreases tumour xenograft growth.Rare mutations provide unique insight into oncogenic potential of STAT transcription factors.FoxO transcription factors in cancer metabolism.Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment.Symmetry and symmetry breaking in cancer: a foundational approach to the cancer problem.LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia.Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling.AIRE promotes androgen-independent prostate cancer by directly regulating IL-6 and modulating tumor microenvironment.Assessing the efficacy of androgen receptor and Sox10 as independent markers of the triple-negative breast cancer subtype by transcriptome profilingA high-throughput method to identify trans-activation domains within transcription factor sequencesREGGAE: a novel approach for the identification of key transcriptional regulatorsELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and CancerA distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutationsTranscription factor networks involved in cell death in the dorsal root ganglia following peripheral nerve injury
P2860
Q26753176-327CA612-F3C2-4146-8E7B-F87C9F2E43B0Q27333970-64B8EE42-A273-4CF3-AF90-09A06690A567Q30234584-481F1F5A-489F-4619-B509-6118ABD86793Q33638827-973FDC4D-4953-4205-B4D6-CE20120C8AE5Q36266718-6CCA7148-2CAE-4EEA-B83D-FA95E524CEBAQ37420954-3BBA96EB-D102-42B0-B2DD-51FBD7915226Q37583178-043A70AB-E18C-4E77-9EE0-979C4C1CDFE1Q38657057-E145D9B2-7B82-4912-8D09-848A28318E2FQ38696706-841E904D-C080-48C0-AA30-339712933C63Q38804041-A3AE8086-C315-483F-B690-28167982F524Q38925481-C31254C7-57F5-463A-8CB7-049AF377A693Q38958946-E34E37A7-F0F4-4053-99EE-B8B07131BDF4Q39012504-0BD8662E-37BA-4A33-8DFD-FDFC156A55AAQ39079853-822B4B61-F172-4A87-B377-83722BD090C6Q39441366-F82CBE42-0C3A-4859-8472-CB3962524AC5Q41330428-340D06CC-A4E2-440D-B24A-37AD45A26718Q42335698-7DFEEA46-CD0F-46B9-9697-57D0644E044BQ42366138-21797E01-B0E2-4250-B570-4F890B0C4F96Q42378493-371C2D8D-C43A-4FBC-A03A-C31B44613BFEQ47107161-39CB5FE3-2392-4C4B-B905-18186695C4DFQ47142295-000E4D97-7D90-4C8C-97F8-B861AD984AA8Q47337796-2809D1C9-D487-4F6E-9232-CB9814FD00ECQ47797194-7574CF16-BF96-445D-8718-D95D27285FF9Q49330004-E2FF6A0A-7AB9-4FF1-9EC0-CD11B26E58D8Q50137602-5D0EE1B4-CD76-4B16-AF55-630C77F51017Q50159459-53269FE7-13F7-4990-BF18-D558810A0D70Q51041591-8D55F7C5-B70A-418E-A889-64D7F79438E7Q52353605-76C648EC-2812-41B7-B113-FDC7AA27D9DCQ52430746-A3735A43-1631-44B6-9D34-EDF192CA5108Q55030833-B3DD1627-0C58-493C-B8E1-C6D133A432AFQ55417295-98302F5B-B21C-43F5-94ED-B42E832E040EQ57117060-1F57E609-5888-4434-9C45-1D7EB6BB9A02Q57232451-3AD7E80E-465F-4744-8E3B-5D3DCC100FF7Q57461511-B8886B52-4245-4275-ABB3-EFC711FF8A42Q58696663-6D604391-43C4-45DC-A687-47624ACC0774Q58718413-CB853DC9-5934-40E5-B616-CA1F1E0C8B34Q58775953-924E26A5-13AD-4910-96C5-AABFED6D1BD9
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Targeting Transcription Factors in Cancer
@ast
Targeting Transcription Factors in Cancer
@en
type
label
Targeting Transcription Factors in Cancer
@ast
Targeting Transcription Factors in Cancer
@en
prefLabel
Targeting Transcription Factors in Cancer
@ast
Targeting Transcription Factors in Cancer
@en
P2860
P1433
P1476
Targeting Transcription Factors in Cancer
@en
P2093
Anand S Bhagwat
Christopher R Vakoc
P2860
P356
10.1016/J.TRECAN.2015.07.001
P577
2015-09-01T00:00:00Z